# Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX

> **NCT01171625** · NA · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 283 (actual)

## Conditions studied

- Coronary Artery Disease
- Aortic Valve Disorder
- Heart Failure
- Aortic Valve Stenosis
- Aortic Valve Insufficiency

## Interventions

- **DEVICE:** Implantation of CEP Magna Ease Model 3300TFX

## Key facts

- **NCT ID:** NCT01171625
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 283 (ACTUAL)
- **Last updated:** 2020-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01171625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01171625, "Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01171625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*